公开(公告)号：US4755562A

公开(公告)日：1988-07-05

申请号：US872654

申请日：1986-06-10

Applicant: William Alexander ,  Mark Anderson ,  Barbara R. Regan

Inventor： William Alexander ,  Mark Anderson ,  Barbara R. Regan

IPC: C08F8/32 ,  C08F8/44

CPC classification number: C08F8/32

Abstract: Surface treating water-absorbent resins with a polyquaternary amine substantially increases both the rate of water absorption and the quantity of water absorbed and retained by the resin. In addition to improved water absorbing properties, the surface-treated resins maintain the necessary "dry feel" required for most applications.

Abstract translation: 具有多元季胺的表面处理吸水树脂显着增加吸水率和吸收并被树脂保留的水量。 除了改进的吸水性能之外，表面处理的树脂保持了大多数应用所需的必要的“干燥感”。

公开(公告)号：USD295658S

公开(公告)日：1988-05-10

申请号：US721759

申请日：1985-04-10

Applicant: Mark Anderson

Designer： Mark Anderson

公开(公告)号：USD275702S

公开(公告)日：1984-09-25

申请号：US339687

申请日：1982-01-15

Applicant: Mark Anderson

Designer： Mark Anderson

公开(公告)号：US10750738B2

公开(公告)日：2020-08-25

申请号：US12099687

申请日：2008-04-08

Applicant: Robert Fishman ,  Robert Havener ,  Ihab Abdel Fattah ,  Anas Abdelazim ,  Scott Newell ,  Thomas H. Bishop ,  Tamer Khayal ,  Stanley Kyi ,  Ron Taylor ,  Doug Harriott ,  Matthew De Remer ,  Paul Murray ,  John Sullivan ,  Mark Anderson ,  Richard Bringham ,  Michael Van Driel ,  Waleed Hassanein

Inventor： Robert Fishman ,  Robert Havener ,  Ihab Abdel Fattah ,  Anas Abdelazim ,  Scott Newell ,  Thomas H. Bishop ,  Tamer Khayal ,  Stanley Kyi ,  Ron Taylor ,  Doug Harriott ,  Matthew De Remer ,  Paul Murray ,  John Sullivan ,  Mark Anderson ,  Richard Bringham ,  Michael Van Driel ,  Waleed Hassanein

IPC: C12Q1/02 ,  C12M1/00 ,  A01N1/02

Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.

公开(公告)号：US09462802B2

公开(公告)日：2016-10-11

申请号：US12099725

申请日：2008-04-08

Applicant: Robert Fishman ,  Robert Havener ,  Ihab Abdel Fattah ,  Anas Abdelazim ,  Scott Newell ,  Tom Bishop ,  Tamer Khayal ,  Stanley Kyi ,  Ron Taylor ,  Doug Harriott ,  Matthew De Remer ,  Paul Murray ,  John Sullivan ,  Mark Anderson ,  Richard Bringham ,  Michael Van Driel ,  Waleed Hassanein

Inventor： Robert Fishman ,  Robert Havener ,  Ihab Abdel Fattah ,  Anas Abdelazim ,  Scott Newell ,  Tom Bishop ,  Tamer Khayal ,  Stanley Kyi ,  Ron Taylor ,  Doug Harriott ,  Matthew De Remer ,  Paul Murray ,  John Sullivan ,  Mark Anderson ,  Richard Bringham ,  Michael Van Driel ,  Waleed Hassanein

IPC: A01N1/02

CPC classification number: A01N1/021 ,  A01N1/02 ,  A01N1/0247

Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.

公开(公告)号：US09247728B2

公开(公告)日：2016-02-02

申请号：US12099715

申请日：2008-04-08

Applicant: Robert Fishman ,  Robert Havener ,  Ihab Abdel Fattah ,  Anas Abdelazim ,  Scott Newell ,  Tom Bishop ,  Tamer Khayal ,  Stanley Kyi ,  Ron Taylor ,  Doug Harriott ,  Matthew De Remer ,  Paul Murray ,  John Sullivan ,  Mark Anderson ,  Richard Bringham ,  Michael Van Driel ,  Waleed Hassanein

Inventor： Robert Fishman ,  Robert Havener ,  Ihab Abdel Fattah ,  Anas Abdelazim ,  Scott Newell ,  Tom Bishop ,  Tamer Khayal ,  Stanley Kyi ,  Ron Taylor ,  Doug Harriott ,  Matthew De Remer ,  Paul Murray ,  John Sullivan ,  Mark Anderson ,  Richard Bringham ,  Michael Van Driel ,  Waleed Hassanein

IPC: A61M16/00 ,  A01N1/02

CPC classification number: A01N1/021 ,  A01N1/02 ,  A01N1/0247

Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.

公开(公告)号：US08962482B2

公开(公告)日：2015-02-24

申请号：US11530150

申请日：2006-09-08

Applicant: Todd Albertson ,  Darin Miller ,  Mark Anderson

Inventor： Todd Albertson ,  Darin Miller ,  Mark Anderson

IPC: H01L21/768

CPC classification number: H01L21/76834 ,  H01L21/76801

Abstract: An integrated circuit interconnect is fabricated by using a mask to form a via in an insulating layer for a conductive plug. After the plug is formed in the via, a thin (e.g.,

Abstract translation: 通过使用掩模在用于导电插塞的绝缘层中形成通孔来制造集成电路互连。 在插塞形成在通孔中之后，在所得到的结构上沉积薄（例如，<100nm）的隔离层。 通过在不同的辐射曝光水平下使用相同的掩模在隔离层中产生开口，以使开口比下面的塞子更窄。 然后形成导线，其通过隔离层中的开口与插头电接触。 通过将导电插塞与相邻的导电线垂直分离和电绝缘，隔离层有利地降低了在导电插塞和附近导电线之间出现不期望的电短路的可能性。

公开(公告)号：US08821067B1

公开(公告)日：2014-09-02

申请号：US13912554

申请日：2013-06-07

Applicant: Mark Anderson

Inventor： Mark Anderson

IPC: B63C3/00 ,  E04F11/09 ,  B63C3/06

CPC classification number: B63C3/06

Abstract: A step that may be attached to a boat lift rail. The boat lift rail may be in between the dock and the boat. Therefore, a user may board the boat from the dock using the step. Further, the step may raise and lower with the lift with the top of the step staying above the surface of the water.

Abstract translation: 一个可能附着在船上铁路上的步骤。 船上的铁路可能在码头和船之间。 因此，用户可以使用该步骤从码头登船。 此外，步骤可以随着台阶的顶部停留在水面以上的升力而升高和降低。

公开(公告)号：US20140079628A1

公开(公告)日：2014-03-20

申请号：US13623144

申请日：2012-09-20

Applicant: G. Mark Anderson ,  Bernard Scallon ,  Michael Naso ,  Ann Cai ,  Cam Ngo

Inventor： G. Mark Anderson ,  Bernard Scallon ,  Michael Naso ,  Ann Cai ,  Cam Ngo

IPC: A61K39/395 ,  A61K51/00 ,  A61P35/00 ,  A61P29/00 ,  A61P11/06 ,  A61P25/00 ,  A61P23/00 ,  A61P37/06 ,  A61P25/24 ,  A61P25/18 ,  C12N5/071 ,  A61P21/02

CPC classification number: C07K16/36 ,  A61K9/0019 ,  A61K31/4164 ,  A61K39/3955 ,  A61K47/6849 ,  A61K51/00 ,  A61K2039/505 ,  A61K2039/507 ,  C07K16/30 ,  C07K16/3023 ,  C07K16/303 ,  C07K16/3038 ,  C07K16/3069 ,  C07K2317/24 ,  C07K2317/52 ,  C07K2317/72 ,  C07K2317/73 ,  C07K2317/732 ,  C07K2317/76 ,  C07K2317/92

Abstract: Isolated anti-tissue factor antibodies, immunoglobulins, cleavage products and other specified portions and variants thereof having enhanced ADCC activity, as well as anti-tissue factor antibody compositions, encoding or complementary nucleic acids, vectors, host cells, compositions, formulations, devices, transgenic animals, transgenic plants, and methods of making and using thereof. The antibodies of the invention bind human tissue factor and demonstrate enhanced ADCC activity. Accordingly, the antibodies can be used in a variety of methods for diagnosing, treating, and/or preventing diseases involving tissue factor, where enhanced ADCC activity is desirable such as cancer.

Abstract translation: 分离的抗组织因子抗体，免疫球蛋白，切割产物和其具有增强的ADCC活性的其它指定部分和变体，以及抗组织因子抗体组合物，编码或互补核酸，载体，宿主细胞，组合物，制剂，装置， 转基因动物，转基因植物及其制备和使用方法。 本发明的抗体结合人组织因子并表现出增强的ADCC活性。 因此，抗体可用于各种诊断，治疗和/或预防涉及组织因子的疾病的方法，其中期望增加ADCC活性，例如癌症。

公开(公告)号：USD670453S1

公开(公告)日：2012-11-06

申请号：US29397972

申请日：2011-07-25

Applicant: Don Knutson ,  Mark Anderson

Designer： Don Knutson ,  Mark Anderson